Riders For The Cure - Working to Cure Cancer

  • Increase font size
  • Default font size
  • Decrease font size
Riders For The Cure's Previous Rides

Sam's Jam IV

Event Date: October 15, 2011

View The Online Flyer


Sam’s Jam is the signature event produced by Riders for the Cure. Sam’s Jam celebrates the life and work of our co-founding member Dr. Samuel Hassenbusch, M.D., Ph.D. “Dr. Sam”, as he was known, was a world-renowned neurosurgeon and researcher who lost his battle with glioblastoma multiforme in 2008. Sam’s Jam honors his spirit, his vitality and most of all, his commitment to patient care and research.

Sam’s Jam features a police-escorted ride to a local venue featuring live music, unique vendors, and entertainment. Our 2008, 2009, and 2010 rides have attracted hundreds of riders and raised nearly $50,000 in donations.

In 2011, fundraising efforts will benefit patients with brain cancer through a research project focusing on progressive brainstem glioma.

The funds raised from this ride were donated to Phase I/II study of reirradiation of recurrent or progressive brainstem glioma.  The main goal of treatment will be to improve symptoms and quality of life. This protocol may identify the optimal dose of re-irradiation and define the efficacy, particularly regarding quality of life, therefore offering a treatment option for patients with an incurable disease.  The principal investigators at MD Anderson Cancer Center for this study are Anita Mahajan, M.D. and Hiral P Fontanilla, M.D.

 

Ride To Work Day

Event Date: June 20, 2011

Ride your motorcycle or scooter on this day to demonstrate:

  • The number of motorcyclists to the general public and to politicians.
  • That motorcyclists are from all occupations and all walks of life.
  • That motorcyclists can reduce traffic and parking congestion in large cities.
  • That motorcycles are for transportation as well as recreation.
  • That motorcycling is a social good.
 

Sam’s Jam III

Event Date: October 16th, 2010

Our third annual ride benefiting The University of Texas MD Anderson Cancer Center happened on October 16th, 2010. The event is named Sam’s Jam III after one of the founding members of Riders for the Cure, the Employee Motorcycle group of MD Anderson Cancer Center.

Read more...
 

Ride For Life

Event Date: June 4, 2011

Ride For Life, a police-escorted motorcycle ride, will take place Saturday, June 4 2011. Registration starts at 9:30 a.m., and kickstands go up at 11am. The cost is $20 per rider, which includes lunch, and a pin. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. There will be door prizes, food and entertainment.

Read more...
 

Ride for Life

Event Date: June 5th, 2010

Another successful ride in support of Cancer Survivors at the Anderson Network Cancer Survivorship Conference.

 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »


Page 1 of 3

Upcoming Rides

Ride for Life 2012:

June 2nd, 2012 at 9:30 A.M.

Ride For Life, a police-escorted motorcycle ride, will take place Saturday, June 2nd 2012.

Registration for this ride starts at 9:30 a.m., and kickstands go up at 11am. The cost is $20 per rider, which includes lunch, and a pin. The ride will start and end at Stubbs Harley-Davidson in Houston on Telephone Road. There will be door prizes, food and entertainment.

Read More? View Our Online Flyer

Sam’s Jam V:

October 13th, 2012

This will be the 5th year for Sam's Jam and we look forward to seeing everyone at the event.

Mark your calendars!

View Our Online Flyer

Studies Currently Supported...

STUDIES SUPPORTED

Phase I/II study of reirradiation of recurrent or progressive brainstem glioma:

 

This study investigates the use of re-irradiation in the highly aggressive form of cancer known as brainstem glioma. This Phase I/II study will be conducted to evaluate the safety of re-irradiation with higher doses. The main goal of treatment will be to improve symptoms and quality of life. This protocol may identify the optimal dose of re-irradiation and define the efficacy, particularly regarding quality of life, therefore offering a treatment option for patients with an incurable disease.

 

Principal Investigators: Anita Mahajan, M.D. and Hiral P Fontanilla, M.D.